Advertisement

Stock value for Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) fell nearly 10 percent Wednesday after the company announced a net loss for the three months that ended in September that was nearly twice as much as analysts expected.

Advertisement
Advertisement